Neurogen Corporation Announces Webcast of September 24 Presentation at UBS Warburg 2007 Global Life Sciences Conference

BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (Nasdaq: NRGN), a drug discovery and development company, announced today that William H. Koster, CEO, will present a Company overview at the UBS 2007 Global Life Sciences Conference on Monday, September 24 at 3:30 p.m. ET.

Back to news